11/5/2019 Health Policy & Reimbursement Update - Take Action
ASCVPR Members Please Take Action!
Last week, you may have seen an AACVPR Reimbursement Update with information about a current bill in the U.S. House of Representatives (HR #4838) that aims to correct drastic reimbursement reductions for cardiac and pulmonary rehabilitation programs located off campus. In that update was a link to AACVPR's new virtual lobbying tool, which can be used to send customized letters to your U.S. representatives, advocating for the bill.
Since that update, more than 500 letters from practitioners, medical directors, physicians, and patients have been sent. Every U.S. House of Representatives signature counts, so we need your full participation to pass this bill. The virtual lobbying tool makes this easy; it takes less than three minutes to send a letter!
Advocate for Your Field in Two Steps:
- Take Action: Send a letter. We have templates for CR/PR practitioners, medical directors/physicians, grateful patients, and hospital administrators (new!).
- Share in Your Network: Post your support on Facebook and Twitter to encourage others to take action with you.
Tips for Taking Action:
- Encourage your hospital administration to send a letter with a personal note about the specific negative impact on your hospital’s services.
- To add your credentials, enter them with your name in the “tell us about yourself” section.
Congratulations to our newest board members elected at our 27th Annual ASCVPR Conference on May 4, 2019!!
Click button below to see photos from the conference!
More photos coming soon!
From left to right: Stephanie Barton, Past President, Ruben Garcia - President, Lauren Egercic - President-elect, Whitney Gil - Secretary-elect, Lisa Strongoli - Treasurer-elect, Terry Lahey - Member at Large, and Jennifer Smith - Membership.
Who can join?
Any health care and/or rehabilitation professional who has an interest in or whose work involves cardiopulmonary rehabilitation and or preventive medicine is welcome to join AACVPR/ASCVPR.